In vitro synergy of caspofungin with licensed and novel antifungal drugs against clinical isolates of Fusarium spp

Medical Mycology
Itamar ShalitNir Osherov

Abstract

Combinations of caspofungin (CAS) with amphotericin-B (AMB), voriconazole (VRC), terbinafine (TRB) and tacrolimus (FK-506) were tested in vitro with 10 Fusarium isolates. MIC and minimal effective concentrations (MEC) were investigated in accord with the CLSI methodology. Drug interactions were assessed by the fractional inhibitory concentration index (FICI). Synergy occurred in 10/10, 9/10, 7/10 and 4/10 isolates with CAS/FK-506, CAS/TRB, CAS/AMB and CAS/VRC, respectively. Caspofungin MECs reached clinically attainable concentrations with FK-506 and TRB. Hyphal length and DiBAC staining demonstrated enhanced inhibition and killing with CAS/FK-506 and CAS/TRB. The combination of CAS/TRB and CAS/FK-506 is strongly synergistic in vitro against Fusarium spp. Our finding should be further studied in animal models of invasive infections caused by this fungus.

References

Dec 26, 2001·Antimicrobial Agents and Chemotherapy·Sevtap ArikanJohn H Rex
Feb 4, 2003·The Journal of Antimicrobial Chemotherapy·Dimitrios P KontoyiannisGregory S May
May 15, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John ApostolidisEmmanuel Nikiforakis
Feb 6, 2004·Diagnostic Microbiology and Infectious Disease·Montserrat OrtonedaJosep Guarro
Sep 16, 2006·The Journal of Antimicrobial Chemotherapy·Brad SpellbergAshraf S Ibrahim
May 17, 2007·Nature Reviews. Microbiology·William J SteinbachJoseph Heitman
Oct 16, 2007·Clinical Microbiology Reviews·Marcio Nucci, Elias Anaissie

❮ Previous
Next ❯

Citations

Aug 13, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J Guarro
Sep 22, 2010·Antimicrobial Agents and Chemotherapy·Janet F StaabKieren A Marr
Nov 28, 2009·International Journal of Antimicrobial Agents·A M Bal
Apr 9, 2013·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Shojiro InanoNobuyoshi Arima
Oct 5, 2016·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Thaís Felli KubiçaSydney Hartz Alves
Dec 17, 2009·The Annals of Pharmacotherapy·Heather L VandenBussche, Dean A Van Loo
Dec 24, 2010·Drugs·Sharon C-A ChenTania C Sorrell
May 1, 2013·Expert Review of Anti-infective Therapy·Nevin Hatipoglu, Husem Hatipoglu
Mar 23, 2011·Expert Review of Anti-infective Therapy·Ayper SomerNuran Salman
Jun 22, 2021·Applied Microbiology and Biotechnology·Qian ZhangZhangyong Song

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.